Published in J Embryol Exp Morphol on December 01, 1962
Retracted Stimulus-triggered fate conversion of somatic cells into pluripotency. Nature (2014) 6.57
Human embryonic stem cells derived by somatic cell nuclear transfer. Cell (2013) 5.91
Nuclear reprogramming to a pluripotent state by three approaches. Nature (2010) 5.26
Epigenetic reprogramming and induced pluripotency. Development (2009) 4.90
Induced pluripotency: history, mechanisms, and applications. Genes Dev (2010) 4.89
Retracted Bidirectional developmental potential in reprogrammed cells with acquired pluripotency. Nature (2014) 4.62
Reprogramming efficiency following somatic cell nuclear transfer is influenced by the differentiation and methylation state of the donor nucleus. Stem Cells (2006) 3.07
Harnessing the potential of induced pluripotent stem cells for regenerative medicine. Nat Cell Biol (2011) 2.74
Differentiation requires continuous regulation. J Cell Biol (1991) 2.56
Slicing across kingdoms: regeneration in plants and animals. Cell (2008) 2.18
Epigenetic programming and reprogramming during development. Nat Struct Mol Biol (2013) 2.13
Induced pluripotent stem cells: opportunities and challenges. Philos Trans R Soc Lond B Biol Sci (2011) 2.09
The double face of the histone variant H3.3. Cell Res (2011) 2.00
Pluripotency and nuclear reprogramming. Philos Trans R Soc Lond B Biol Sci (2008) 1.82
Pioneer transcription factors in cell reprogramming. Genes Dev (2014) 1.71
Hallmarks of pluripotency. Nature (2015) 1.60
From teratocarcinomas to embryonic stem cells. Philos Trans R Soc Lond B Biol Sci (2002) 1.56
Stem cell aging: mechanisms, regulators and therapeutic opportunities. Nat Med (2014) 1.52
Epigenetic memory of active gene transcription is inherited through somatic cell nuclear transfer. Proc Natl Acad Sci U S A (2005) 1.50
Segregation during ascidian embryogenesis of egg cytoplasmic information for tissue-specific enzyme development. Proc Natl Acad Sci U S A (1973) 1.45
Nuclear reprogramming and stem cell creation. Proc Natl Acad Sci U S A (2003) 1.44
Biomedical Application of Dental Tissue-Derived Induced Pluripotent Stem Cells. Stem Cells Int (2016) 1.42
The first half-century of nuclear transplantation. Proc Natl Acad Sci U S A (2003) 1.37
Maintaining differentiated cellular identity. Nat Rev Genet (2012) 1.32
Expression of muscle genes in heterokaryons depends on gene dosage. J Cell Biol (1986) 1.21
Embryonic development following somatic cell nuclear transfer impeded by persisting histone methylation. Cell (2014) 1.18
Quantitative proteomics of Xenopus laevis embryos: expression kinetics of nearly 4000 proteins during early development. Sci Rep (2014) 1.18
A decade of transcription factor-mediated reprogramming to pluripotency. Nat Rev Mol Cell Biol (2016) 1.16
Dedifferentiation and reprogramming: origins of cancer stem cells. EMBO Rep (2014) 1.16
Epigenetic factors influencing resistance to nuclear reprogramming. Trends Genet (2011) 1.14
iPS cell technologies: significance and applications to CNS regeneration and disease. Mol Brain (2014) 1.14
Nuclear transfer to eggs and oocytes. Cold Spring Harb Perspect Biol (2011) 1.13
From intestine to muscle: nuclear reprogramming through defective cloned embryos. Proc Natl Acad Sci U S A (2002) 1.11
Robert Edwards: the path to IVF. Reprod Biomed Online (2011) 1.11
From stealing fire to cellular reprogramming: a scientific history leading to the 2012 Nobel Prize. Stem Cell Reports (2013) 1.10
Gene therapy on the move. EMBO Mol Med (2013) 1.10
Autologous blood cell therapies from pluripotent stem cells. Blood Rev (2009) 1.09
microRNAs, the cell's Nepenthe: clearing the past during the maternal-to-zygotic transition and cellular reprogramming. Curr Opin Genet Dev (2010) 1.08
Reactive oxygen species in normal and tumor stem cells. Adv Cancer Res (2014) 1.06
Induced Pluripotent Stem Cells Meet Genome Editing. Cell Stem Cell (2016) 1.06
Induced pluripotent stem (iPS) cells as in vitro models of human neurogenetic disorders. Neurogenetics (2008) 1.06
Programming DNA replication origins and chromosome organization. Chromosome Res (2010) 1.05
Reprogramming of cell fate: epigenetic memory and the erasure of memories past. EMBO J (2015) 1.05
Cardiac regeneration: current therapies-future concepts. J Thorac Dis (2013) 1.04
Totipotency, pluripotency and nuclear reprogramming. Adv Biochem Eng Biotechnol (2009) 1.03
Direct cardiac reprogramming: from developmental biology to cardiac regeneration. Circ Res (2013) 1.02
Transcriptional activation of Xenopus class III genes in chromatin isolated from sperm and somatic nuclei. Nucleic Acids Res (1989) 1.02
Using human induced pluripotent stem cells to treat retinal disease. Prog Retin Eye Res (2013) 1.00
Induced pluripotent stem cells: applications in regenerative medicine, disease modeling, and drug discovery. Front Cell Dev Biol (2015) 1.00
Xenopus oocytes reactivate muscle gene transcription in transplanted somatic nuclei independently of myogenic factors. Development (2009) 0.99
Studies on the developmental potentiality of cultured cell nuclei of fish. Int J Biol Sci (2010) 0.99
Cell specialization in the epithelium of the small intestine of feeding Xenopus laevis tadpoles. J Anat (1978) 0.98
RPGR: Its role in photoreceptor physiology, human disease, and future therapies. Exp Eye Res (2015) 0.97
Notch inhibition allows oncogene-independent generation of iPS cells. Nat Chem Biol (2014) 0.95
Histone variant H3.3 is an essential maternal factor for oocyte reprogramming. Proc Natl Acad Sci U S A (2014) 0.94
Large animal induced pluripotent stem cells as pre-clinical models for studying human disease. J Cell Mol Med (2012) 0.93
Cell rewind wins medicine Nobel. Nature (2012) 0.92
Purpose and regulation of stem cells: a systems-biology view from the Caenorhabditis elegans germ line. J Pathol (2009) 0.92
Ekiden to iPS Cells. Nat Med (2009) 0.89
Back to the future: how human induced pluripotent stem cells will transform regenerative medicine. Hum Mol Genet (2013) 0.89
The Maternal-to-Zygotic Transition During Vertebrate Development: A Model for Reprogramming. Curr Top Dev Biol (2015) 0.89
Scientific and clinical opportunities for modeling blood disorders with embryonic stem cells. Blood (2005) 0.88
Cancer stem cell targeted therapy: progress amid controversies. Oncotarget (2015) 0.88
Systematic identification of cis-silenced genes by trans complementation. Hum Mol Genet (2008) 0.88
Pluripotent stem cells and gene therapy. Transl Res (2013) 0.88
Transitions between epithelial and mesenchymal states during cell fate conversions. Protein Cell (2014) 0.87
Actin, actin-binding proteins, and actin-related proteins in the nucleus. Histochem Cell Biol (2016) 0.86
Influence of spermine and reduced temperature on the ability of transplanted nuclei to promote normal development in eggs of Rana pipiens. Proc Natl Acad Sci U S A (1970) 0.86
Nuclear reprogramming in eggs. Nat Med (2009) 0.86
iPS cells: insights into basic biology. Cell (2009) 0.86
Evidence for a critical role of gene occlusion in cell fate restriction. Cell Res (2011) 0.85
Induced pluripotent stem cells: emerging techniques for nuclear reprogramming. Antioxid Redox Signal (2011) 0.85
Mismatch repair deficiencies transforming stem cells into cancer stem cells and therapeutic implications. Mol Cancer (2007) 0.85
Programming and Reprogramming Cellular Age in the Era of Induced Pluripotency. Cell Stem Cell (2015) 0.85
Patient-specific pluripotent stem cells: promises and challenges. Nat Rev Endocrinol (2009) 0.85
Cloning, stem cells, and the current national debate: incorporating ethics into a large introductory biology course. Cell Biol Educ (2002) 0.85
Dedifferentiation of neurons precedes tumor formation in Lola mutants. Dev Cell (2014) 0.85
Understanding the roadmaps to induced pluripotency. Cell Death Dis (2014) 0.85
Translation of Human-Induced Pluripotent Stem Cells: From Clinical Trial in a Dish to Precision Medicine. J Am Coll Cardiol (2016) 0.85
Cycling through developmental decisions: how cell cycle dynamics control pluripotency, differentiation and reprogramming. Development (2016) 0.84
Induction of pluripotency by defined factors. Proc Jpn Acad Ser B Phys Biol Sci (2014) 0.84
The pharmacology of regenerative medicine. Pharmacol Rev (2013) 0.83
Programming and reprogramming neuronal subtypes in the central nervous system. Dev Neurobiol (2012) 0.83
Ethical attitudes of German specialists in reproductive medicine and legal regulation of preimplantation sex selection in Germany. PLoS One (2013) 0.83
Small but significant: inter- and intrapatient variations in iPS cell-based disease modeling. Mol Ther (2013) 0.82
Reshaping the transcriptional frontier: epigenetics and somatic cell nuclear transfer. Mol Reprod Dev (2013) 0.82
Neural Stem Cells (NSCs) and Proteomics. Mol Cell Proteomics (2015) 0.82
Optimization and comparison of bottom-up proteomic sample preparation for early-stage Xenopus laevis embryos. Anal Bioanal Chem (2016) 0.82
Drug discovery models and toxicity testing using embryonic and induced pluripotent stem-cell-derived cardiac and neuronal cells. Stem Cells Int (2012) 0.82
Nuclear reprogramming of sperm and somatic nuclei in eggs and oocytes. Reprod Med Biol (2013) 0.81
Transcription factor-mediated reprogramming toward hematopoietic stem cells. EMBO J (2015) 0.81
Transcriptional and epigenetic mechanisms of cellular reprogramming to induced pluripotency. Epigenomics (2016) 0.81
Built to rebuild: in search of organizing principles in plant regeneration. Curr Opin Genet Dev (2010) 0.81
Adult cell plasticity in vivo: de-differentiation and transdifferentiation are back in style. Nat Rev Mol Cell Biol (2016) 0.81
Induced pluripotent stem cells: Mechanisms, achievements and perspectives in farm animals. World J Stem Cells (2015) 0.80
Cell-based therapy technology classifications and translational challenges. Philos Trans R Soc Lond B Biol Sci (2015) 0.80
A poor imitation of a natural process: a call to reconsider the iPSC engineering technique. Cell Cycle (2012) 0.80
Differences in cell division rates drive the evolution of terminal differentiation in microbes. PLoS Comput Biol (2012) 0.80
Systematic mapping of occluded genes by cell fusion reveals prevalence and stability of cis-mediated silencing in somatic cells. Genome Res (2013) 0.79
ABSENCE OF RIBOSOMAL RNA SYNTHESIS IN THE ANUCLEOLATE MUTANT OF XENOPUS LAEVIS. Proc Natl Acad Sci U S A (1964) 5.67
Sexually mature individuals of Xenopus laevis from the transplantation of single somatic nuclei. Nature (1958) 3.16
Adult frogs derived from the nuclei of single somatic cells. Dev Biol (1962) 1.76
The developmental capacity of nuclei taken from differentiating endoderm cells of Xenopus laevis. J Embryol Exp Morphol (1960) 1.41
CYTOPLASMIC REGULATION OF RNA SYNTHESIS AND NUCLEOLUS FORMATION IN DEVELOPING EMBRYOS OF XENOPUS LAEVIS. J Mol Biol (1965) 1.21
The transplantation of nuclei between two species of Xenopus. Dev Biol (1962) 1.09
A description of the technique for nuclear transplantation in Xenopus laevis. J Embryol Exp Morphol (1960) 0.94
Nuclear transfer in amphibia and the problem of the potentialities of the nuclei of differentiating tissues. Exp Cell Res (1959) 0.90
Multiple genetically identical frogs. J Hered (1963) 0.83
Factors responsible for the abnormal development of embryos obtained by nuclear transplantation in Xenopus laevis. J Embryol Exp Morphol (1960) 0.83
Tetraploid frogs. J Exp Zool (1959) 0.76